Submit Deal

ATHYRIUM CAPITAL MANAGEMENT

HQ - New York

Summary

Athyrium Capital Management is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector.

Deals Overview

Total Deals6

Valued Deals3

Total Value£ 3.07 B

Avg. Deal Size£ 1.02 B

Market Context

Senior Management

Paul Wakefield
CFO
Jeffrey Ferrell
Managing Partner
Andrew Hyman
General Counsel

Investment Criteria

Target Equity CheckUSD 25-150m

Fund CurrencyUSD

Total funds raised$1-5bn

Investment Strategies

Special Situations

PIPE

Venture

Geographic Preferences

United States

Industry Preferences

Medical Equipment

Pharmaceuticals

Software

Digital Services

Health Care Services

Biotechnology

Medical Services

Sort

06 Oct 2020|United States|Health Care Services

Target: CLOVER HEALTH

Bidder: SOCIAL CAPITAL HEDOSOPHIA

22 Service Providers

7 Target | 7 Bidder | 8 Vendor

64 Dealmakers

32 Target | 18 Bidder | 14 Vendor

£ 2.85 B

Value

05 May 2021|United States|Biotechnology

Target: CHIASMA

Bidder: HIGHBRIDGE CAPITAL MANAGEMENT

13 Service Providers

4 Target | 9 Bidder

18 Dealmakers

7 Target | 11 Bidder

£ 195 M

Value

25 May 2022|United Kingdom|Software

Target: UMOTIF

Bidder: ATHYRIUM CAPITAL MANAGEMENT

5 Service Providers

2 Target | 3 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 20 M

Value

07 Feb 2023|United States|Media Agencies

Target: ERUPTR

Bidder: AMULET CAPITAL PARTNERS

7 Service Providers

3 Target | 4 Bidder

8 Dealmakers

3 Target | 5 Bidder

n/a

Value

12 Mar 2024|United States|Biotechnology

Target: ALCRESTA THERAPEUTICS

Bidder: LINDEN CAPITAL PARTNERS

5 Service Providers

2 Target | 1 Bidder | 2 Vendor

12 Dealmakers

6 Target | 1 Bidder | 5 Vendor

n/a

Value

03 Feb 2025|United States|Pharmaceuticals

Target: PHARMACEUTICS INTERNATIONAL INC (PII)

Bidder: JABIL INC

6 Service Providers

2 Target | 2 Bidder | 2 Vendor

10 Dealmakers

2 Target | 6 Bidder | 2 Vendor

n/a

Value